Sort
82,697 grants matching “vaccine development”
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$910,425Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2013 · CA
Accelerated public health and biomedical research on priority public health objectives through collaboration between US NIH and WHO
$910,421Martin Friede · World Health Organization · U01 · FY2022 · AI
Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity
$910,412Ofer Levy · Boston Children'S Hospital · U19 · FY2019 · AI
MOLECULAR AND CELLULAR PATHOGENESES OF URINARY INFECTION
$910,379University Of Maryland Baltimore · P01 · FY2001 · DK
Clinical Studies on the Mechanisms of DF/DHF
$910,210Sharone Green · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · AI
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection
$910,053Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · AI
Optimizing AAV delivery of bNAbs for HIV prevention
$909,998Matthew Ryan Gardner · Emory University · R01 · FY2023 · AI
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles
$909,998Rui Kong · Emory University · R01 · FY2024 · AI
Defining BCR evolution during immunization
$909,731Leonidas A Stamatatos · Seattle Biomedical Research Institute · R01 · FY2014 · AI
Immunotherapeutics and vaccines against anthrax, plague and tularemia
$909,729Zheng W Chen · University Of Illinois At Chicago · U01 · FY2007 · AI
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
$909,657Anne Rietz · Kovina Therapeutics Inc. · R44 · FY2023 · CA
Outer Membrance Protein vaccinogens of Treponema pallium
$909,651Justin D. Radolf · University Of Connecticut Sch Of Med/Dnt · U19 · FY2023 · AI
Towards a Vaccine to Prevent Toxoplasmosis
$909,635Rima L McLeod · University Of Chicago · U01 · FY2008 · AI
IMPACT OF FARMING ENVIRONMENT ON IMMUNE MATURATION AND RESPIRATORY HEALTH
$909,632James E. Gern · University Of Wisconsin-Madison · U19 · FY2014 · AI
Forward Genetic Analysis of Innate Immune Signaling
$909,545Bruce A Beutler · Scripps Research Institute, The · U19 · FY2012 · AI
INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER
$909,357Luke O. Russell · Vyriad, Inc. · R44 · FY2019 · CA
Strategies for Prevention of Autoimmunity
$909,292Stanford University · U19 · FY2004 · DK
Strategies for inducing bnAbs against QNES by infection with SHIVs
$909,236Shiu-Lok Hu · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2012 · AI
Optimizing AAV delivery of bNAbs for HIV prevention
$908,948Matthew Ryan Gardner · Emory University · R01 · FY2024 · AI
Development of a rapid response nucleic acid vaccine strategy for coronavirusepidemics
$908,934Kenneth C Bagley · Orlance, Inc. · R44 · FY2020 · AI
Laboratory And Preclinical Studies Of Flaviviruses
$908,864Stephen Whitehead · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Design of native-like SOSIP trimers
$908,847John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2016 · AI
A Mucosal Vaccine for HSV-2
$908,733Kejian Yang · Biomedical Research Models, Inc. · R44 · FY2010 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$908,727Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
MOLECULAR AND CELLULAR PATHOGENESES OF URINARY INFECTION
$908,706University Of Maryland Baltimore · P01 · FY2000 · DK